posted on 2023-03-21, 19:09authored bySebastian Dekkers, Birgit Caspar, Joëlle Goulding, Nicholas D. Kindon, Laura E. Kilpatrick, Leigh A. Stoddart, Stephen J. Briddon, Barrie Kellam, Stephen J. Hill, Michael J. Stocks
The C–X–C
chemokine receptor type 4, or CXCR4, is
a chemokine receptor found to promote cancer progression and metastasis
of various cancer cell types. To investigate the pharmacology of this
receptor, and to further elucidate its role in cancer, novel chemical
tools are a necessity. In the present study, using classic medicinal
chemistry approaches, small-molecule-based fluorescent probes were
designed and synthesized based on previously reported small-molecule
antagonists. Here, we report the development of three distinct chemical
classes of fluorescent probes that show specific binding to the CXCR4
receptor in a novel fluorescence-based NanoBRET binding assay (pKD ranging 6.6–7.1). Due to their retained
affinity at CXCR4, we furthermore report their use in competition
binding experiments and confocal microscopy to investigate the pharmacology
and cellular distribution of this receptor.